DMAC Stock-Based Compensation
Diamedica Therapeutics Inc · Stock-Based Compensation
DMAC Stock-Based Compensation
Latest reported$3.13Mperiod ending
DMAC Stock-Based Comp ($0.00 → $3.13M)
Annual stock-based compensation
High-resolution chart · PNG
DMAC stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 3,846,000 | |
| 2,085,000 | |
| 1,683,000 | |
| 1,502,000 | |
| 1,558,000 | |
| 1,843,000 | |
| 1,164,000 | |
| 620,000 | |
| 409,000 | |
| 263,310 | |
| 125,487 | |
| 343,303 | |
| 704,573 | |
| 1,032,071 | |
| 0 | |
| 294,486 | |
| 252,398 | |
| 155,331 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |